The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
In Vitro Characterization of Conditions for Amyloid-β Peptide Oligomerization and Fibrillogenesis
Open accessAbstract
Extensive research causally links amyloid-beta peptide (A beta) to Alzheimer's disease, although the pathologically relevant A beta conformation remains unclear. A beta spontaneously aggregates into the fibrils that deposit in senile plaques. However, recent in vivo and in vitro reports describe a potent biological activity for oligomeric assemblies of A beta. To consistently prepare in vitro oligomeric and fibrillar forms of A beta 1-42, a detailed knowledge of how solution parameters influence structure is required. This manuscript represents the first study using a single chemically and structurally homogeneous unaggregated starting material to demonstrate that the formation of oligomers, fibrils, and fibrillar aggregates is determined by time, concentration, temperature, pH, ionic strength, and A beta species. We recently reported that oligomers inhibit neuronal viability 10-fold more than fibrils and approximately 40-fold more than unaggregated peptide, with oligomeric A beta 1-42-induced neurotoxicity significant at 10 nm. In addition, we were able to differentiate by structure and neurotoxic activity wild-type A beta1-42 from isoforms containing familial mutations (Dahlgren, K. N., Manelli, A. M., Stine, W. B., Jr., Baker, L. K., Krafft, G. A., and LaDu, M. J. (2002) J. Biol. Chem. 277, 32046-32053). Understanding the biological role of specific A beta conformations may define the link between A beta and Alzheimer's disease, re-focusing therapeutic approaches by identifying the pernicious species of A beta ultimately responsible for the cognitive dysfunction that defines the disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The 48 h total incubation leads to mature Aβ42 fibrils, as observed by TEM (Figure 10, panel a) while the Western blot shows the presence of higher order Aβ42 oligomers (Figure 10, lane a), likely due to an assembly-disassembly equilibrium that is established for mature Aβ fibrils.89–91”
From Bifunctional Compounds for Controlling Metal-Mediated Aggregation of the Aβ42Peptide (2012) · cites this paper as [91]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In addition, the MOAB-2-based oA42 ELISA detects oligomeric but not monomeric A42 using synthetic preparations characterized previously by our laboratory (data not shown) (47,48).”
From APOE4-specific Changes in Aβ Accumulation in a New Transgenic Mouse Model of Alzheimer Disease (2012) · cites this paper as [48]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506
Self-citationImmunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases
Bucciantini, M., Giannoni, E., Chiti, F., Baroni, F., Formigli, L., Zurdo, J., Taddei, N., Ramponi, G., Dobson, C. M., & Stefani, M. (2002) · Nature · doi:10.1038/416507a · Cited by 2,434
Citron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A. Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I., & Selkoe, D. J. (1992) · Nature · doi:10.1038/360672a0 · Cited by 1,757
Conway, K. A., Lee, S., Rochet, J., Ding, T. T., Williamson, R. E., & Lansbury, P. T. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.571 · Cited by 1,559
Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease
Lue, L.-F., Kuo, Y.-M., Roher, A. E., Brachova, L., Shen, Y., Sue, L., Beach, T., Kurth, J. H., Rydel, R. E., & Rogers, J. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65184-x · Cited by 1,530
Formation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Aβ42 Fibrils
Götz, J., Chen, F., van Dorpe, J., & Nitsch, R. M. (2001) · Science · doi:10.1126/science.1062097 · Cited by 1,526
Flagged first, then by citations
Research works printed but not linked: 3
- Hou, 2002, J. Biol. Chem., 26, 26
- DePace, 2002, Nat. Struct. Biol., 9, 389
- Fezoui, 2002, J. Biol. Chem., 30, 30
Cited by
Sorted by citations
Items 701–800 of 999
Corti, R., Cox, A., Cassina, V., Nardo, L., Salerno, D., Marrano, C. A., Missana, N., Andreozzi, P., Silva, P. J., Stellacci, F., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031066 · Cited by 13
Kuszczyk, M. A., Sadowski, M. J., Antkiewicz‐Michaluk, L., & Łazarewicz, J. W. (2013) · Neurotoxicity Research · doi:10.1007/s12640-013-9440-1 · Cited by 13
Effects of amyloid peptides on A-type K+ currents ofDrosophila larval cholinergic neurons
Kidd, J. F., Brown, L. A., & Sattelle, D. B. (2006) · Journal of Neurobiology · doi:10.1002/neu.20227 · Cited by 13
Thu, V. T. A., Hoang, T. X., & Kim, J. Y. (2023) · BioMed Research International · doi:10.1155/2023/3483411 · Cited by 12
Cheng, T., Afshan, N., Jiao, J., & Jiao, J. (2024) · Biosensors and Bioelectronics X · doi:10.1016/j.biosx.2024.100528 · Cited by 12
Kim, H. Y., & Choi, I. (2015) · Nanoscale · doi:10.1039/c5nr06517h · Cited by 12
A Weakly Clustered N terminus Inhibits Aβ(1–40) Amyloidogenesis
Lim, K. H. (2006) · ChemBioChem · doi:10.1002/cbic.200600270 · Cited by 12
Modeling Amyloid-Beta as Homogeneous Dodecamers and in Complex with Cellular Prion Protein
Gallion, S. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049375 · Cited by 14
Yin, Y., Zhao, Y., Han, S., Zhang, N., Chen, H., & Wang, X. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170246 · Cited by 12
Acetylation of Aβ 40 Alters Aggregation in the Presence and Absence of Lipid Membranes
Pilkington, A. W., Schupp, J. E., Nyman, M., Valentine, S. J., Smith, D. M., & Legleiter, J. A. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00483 · Cited by 12
He, P., Schulz, P., & Sierks, M. R. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.015327 · Cited by 11
Wang, X., Chen, R., Hu, J., & Yuan, W. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.09.182 · Cited by 13
Alzheimer amyloid-β peptides block the activation of C/EBPβ and C/EBPδ in glial cells
Samuelsson, M., Ramberg, V., & Iverfeldt, K. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.03.150 · Cited by 12
Reciprocal modulation of Aβ42 aggregation by copper and homocysteine
Keskitalo, S., Farkas, M., Hanenberg, M., Szodorai, A., Kulic, L., Semmler, A., Weller, M., Nitsch, R. M., & Linnebank, M. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00237 · Cited by 13
82-kDa choline acetyltransferase and SATB1 localize to β-amyloid induced matrix attachment regions
Winick‐Ng, W., Caetano, F. A., Winick‐Ng, J., Morey, T. M., Heit, B., & Rylett, R. J. (2016) · Scientific Reports · doi:10.1038/srep23914 · Cited by 13
Lambracht‐Washington, D., Fu, M., Wight‐Carter, M., Riegel, M. S., & Rosenberg, R. N. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-160947 · Cited by 12
Prakash, P., Lantz, T. C., Jethava, K. P., & Chopra, G. (2019) · Methods and Protocols · doi:10.3390/mps2020048 · Cited by 12
Effects of Physical Damage in the Intermediate Phase on the Progression of Amyloid β Fibrillization
Tashiro, R., Taguchi, H., Hidaka, K., Endo, M., & Sugiyama, H. (2019) · Chemistry - An Asian Journal · doi:10.1002/asia.201901193 · Cited by 12
Amyloid Metabolism and Amyloid-Targeting Blood-Based Biomarkers of Alzheimer’s Disease
Pyun, J., Kang, M. J., Ryoo, N., Suh, J., Youn, Y. C., Park, Y. H., & Kim, S. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200104 · Cited by 11
Propolis Promotes Memantine-Dependent Rescue of Cognitive Deficits in APP-KI Mice
Moriguchi, S., Inagaki, R., Saito, T., Saido, T. C., & Fukunaga, K. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02876-6 · Cited by 14
Luminometric Nanoparticle-Based Assay for High Sensitivity Detection of β-Amyloid Aggregation
Pihlasalo, S., Deguchi, T., Virtamo, M., Jacobino, J., Chary, K., Lopez‐Picon, F. R., Brunhofer, G., Huttunen, R. J., Fallarero, A., Vuorela, P. M., et al. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.6b04266 · Cited by 12
Shifting the balance: soluble ADAM10 as a potential treatment for Alzheimer's disease
Hershkovits, A. S., Gelley, S., Hanna, R., Kleifeld, O., Shulman, A., & Fishman, A. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1171123 · Cited by 12
Dynamic properties of pH-dependent structural organization of the amyloidogenic β-protein (1-40)
Rubinstein, A. I., Lyubchenko, Y. L., & Sherman, S. (2009) · Prion · doi:10.4161/pri.3.1.8388 · Cited by 11
A label-free high-throughput protein solubility assay and its application to Aβ40
Lindberg, M., Axell, E., Sparr, E., & Linse, S. S. (2024) · Biophysical Chemistry · doi:10.1016/j.bpc.2023.107165 · Cited by 13
Nonfibrillar Abeta1–42 Inhibits Glutamate Uptake and Phosphorylates p38 in Human Fibroblasts
Zoia, C., Riva, C., Isella, V., Proserpio, P., Terruzzi, A., Arban, S., Salerno, D., Cassina, V., Mantegazza, F., Tremolizzo, L., et al. (2010) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e3181f9860f · Cited by 11
The role of calsyntenin‐3 in dystrophic neurite formation in A lzheimer's disease brain
Uchida, Y., & Gomi, F. (2016) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.12737 · Cited by 11
Kootar, S., Frandemiche, M., Dhib, G., Mouska, X., Lorivel, T., Poupon, G., Hunt, H., Tronche, F., Bethus, I., Barik, J., et al. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.07.001 · Cited by 11
Impaired hippocampal and thalamic acetylcholine release in P301L tau-transgenic mice
Stein, C., Koch, K. A., Hopfeld, J., Lobentanzer, S., Lau, H., & Klein, J. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.07.014 · Cited by 11
Wang, G., Dai, J., & Lu, X. (2019) · Journal of Cluster Science · doi:10.1007/s10876-019-01735-0 · Cited by 11
Wu, L., Zheng, Q., Guo, Y., Zhang, K., Luo, J., Xiao, S., Li, W., & Yang, M. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.112783 · Cited by 11
Alsalahat, I., Al‐Majdoub, Z. M., Taha, M. O., Barber, J., Aojula, H. S., Hodson, N. W., & Freeman, S. (2021) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2021.100943 · Cited by 11
Klein, W. L. (2007) · Springer eBooks · doi:10.1007/0-387-25919-8_4 · Cited by 11
Nanoparticles for Diagnosis and/or Treatment of Alzheimer's Disease
Antimisiaris, S. G., Mourtas, S., Markoutsa, E., Σκούρας, Α., & Παπαδιά, Κ. (2014) · Advanced Healthcare Materials · doi:10.1002/9781118774205.ch4 · Cited by 11
Role of Alginate Composition on Copper Ion Uptake in the Presence of Histidine or Beta-Amyloid
Mahl, C. R. A., Bataglioli, R. A., Calais, G. B., Taketa, T. B., & Beppu, M. M. (2022) · Molecules · doi:10.3390/molecules27238334 · Cited by 10
Sun, K. T., & Mok, S. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2024.e00512 · Cited by 12
Lee, S. S., & Lee, L. P. (2014) · Nanoscale · doi:10.1039/c3nr06269d · Cited by 10
Awad, L., Jejelava, N., Burai, R., & Lashuel, H. A. (2016) · ChemBioChem · doi:10.1002/cbic.201600474 · Cited by 10
Chen, Y., Su, Y., Run, X., Sun, Z., Wang, T., Sun, S., & Liang, Z. (2012) · Journal of Molecular Neuroscience · doi:10.1007/s12031-012-9938-7 · Cited by 10
Human eukaryotic elongation factor 1A forms oligomers through specific cysteine residues
Liu, T., Yu, Y., Wang, D., Xiao, Y., Du, G., Wu, L., Ding, M., Li, L., & Wu, C. (2015) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmv113 · Cited by 10
The Amyloid Aggregation Accelerator Diacetyl Prevents Cognitive Decline in Alzheimer’s Mouse Models
Xie, W., Kim, K., Vince, R., & More, S. S. (2021) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.1c00089 · Cited by 11
Surolia, I., Sinha, S., Sarkar, D. P., Reddy, P. Y., Reddy, G. B., & Surolia, A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002927 · Cited by 10
Conformational Behavior and Aggregation of Ataxin-3 in SDS
Saunders, H., Hughes, V. A., Cappai, R., & Bottomley, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069416 · Cited by 9
Flow of essential elements in subcellular fractions during oxidative stress
Lago, L., Nunes, E. A., Vigato, A. A., Souza, V. C. O., Barbosa, F., Sato, J. R., Batista, B. L., & Cerchiaro, G. (2017) · BioMetals · doi:10.1007/s10534-016-9988-3 · Cited by 10
Elnagar, M. R., Walls, A. B., Helal, G. K., Hamada, F. M. A., Thomsen, M. S., & Jensen, A. A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0189513 · Cited by 11
Wesén, E. V., Lundmark, R., & Esbjörner, E. K. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00053 · Cited by 9
Szilágyi, A., Kardos, J., Osváth, S., Barna, L., & Závodszky, P. (2007) · Springer eBooks · doi:10.1007/978-0-387-30379-6_10 · Cited by 10
Alzheimer's disease protein Aβ1–42 does not disrupt isolated synaptic vesicles
Allen, P. B., & Chiu, D. T. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.02.002 · Cited by 10
Numaguchi, Y., Tsukakoshi, K., Takeuchi, N., Suzuki, Y., Ikebukuro, K., & Kawano, R. (2023) · PNAS Nexus · doi:10.1093/pnasnexus/pgad437 · Cited by 9
Liu, X., Chen, P., Wu, W., Zhong, M., Dong, S., Lin, H., Dai, C., Zhang, Z., Lin, S., Che, C., et al. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.123085 · Cited by 9
Distinct effects of SDC3 and FGFRL1 on selective neurodegeneration in AD and PD
Wang, J., Chen, P., Hu, B., Cai, F., Xu, Q., Pan, S., Wu, Y., & Song, W. (2023) · The FASEB Journal · doi:10.1096/fj.202201359r · Cited by 10
EPR Studies of Aβ42 Oligomers Indicate a Parallel In-Register β-Sheet Structure
Jang, C., Barron, D. P., Duo, L., Ma, C., Seabaugh, H., & Guo, Z. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00364 · Cited by 9
Min-Kaung-Wint-Mon, Kida, H., Kanehisa, I., Kurose, M., Ishikawa, J., Sakimoto, Y., Paw-Min-Thein-Oo, Kimura, R., & Mitsushima, D. (2024) · Biomolecules · doi:10.3390/biom14111425 · Cited by 8
PrP106-126 and Aβ1-42 Peptides Induce BV-2 Microglia Chemotaxis and Proliferation
Tu, J., Yang, L., Zhou, X., Qi, K., Wang, J., Kouadir, M., Xu, L., Yin, X., & Zhao, D. (2013) · Journal of Molecular Neuroscience · doi:10.1007/s12031-013-0140-3 · Cited by 9
Oligomerization Alters Binding Affinity between Amyloid Beta and a Modulator of Peptide Aggregation
Hilt, S., Rojalin, T., Viitala, T., Koivuniemi, A., Bunker, A., Wachsmann‐Hogiu, S., Kálai, T., Hideg, K., Yliperttula, M. L., & Voss, J. C. (2017) · The Journal of Physical Chemistry C · doi:10.1021/acs.jpcc.7b06164 · Cited by 9
Mutual structural effects of unmodified and pyroglutamylated amyloid β peptides during aggregation
Abedin, F., & Tatulian, S. A. (2021) · Journal of Peptide Science · doi:10.1002/psc.3312 · Cited by 9
Dehghani, M., Jalal, R., & Rashidi, M. (2021) · Biophysical Chemistry · doi:10.1016/j.bpc.2021.106612 · Cited by 9
Cazzaro, S., Zhao, X., Zhao, V. K., Kim, Y. K., & Woo, J. A. (2023) · Human Molecular Genetics · doi:10.1093/hmg/ddad006 · Cited by 9
SorCS1 inhibits amyloid-β binding to neurexin and rescues amyloid-β–induced synaptic pathology
Lee, A. K., Yi, N., Khaled, H., Feller, B., Chofflet, N., & Takahashi, H. (2023) · Life Science Alliance · doi:10.26508/lsa.202201681 · Cited by 11
Feld, M., Galli, C., Piccini, A., & Romano, A. G. (2007) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2007.08.011 · Cited by 9
Microtubule modification influences cellular response to amyloid-β exposure
Shamitko-Klingensmith, N. M., Boyd, J. W., & Legleiter, J. A. (2016) · AIMS Biophysics · doi:10.3934/biophy.2016.2.261 · Cited by 9
How Salt and Temperature Drive Reentrant Condensation of Aβ40
Sarkar, S., & Mondal, J. (2024) · Biochemistry · doi:10.1021/acs.biochem.4c00412 · Cited by 8
Novel Copper Chelators Enhance Spatial Memory and Biochemical Outcomes in Alzheimer’s Disease Model
Camargo, M. L. M., Farias, A. B., Bertazzo, G. B., Gomes, R. N., Gomes, K. S., Bosquetti, L. M., Takada, S. H., Braga, F. C., Augusto, C. C., Batista, B. L., et al. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00291 · Cited by 8
Бунеева, О. А., Gnedenko, O. V., Medvedeva, M. V., Ivanov, A. S., & Medvedev, A. E. (2016) · Biomeditsinskaya Khimiya · doi:10.18097/pbmc20166206720 · Cited by 8
Preparation and Characterization of Zn(II)-Stabilized Aβ42 Oligomers
Díaz, A. G., Cataldi, R., Mannini, B., & Vendruscolo, M. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00084 · Cited by 10
Chaulagain, B., & Singh, J. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.4c00811 · Cited by 10
He, Z., Zhang, W., Chen, P., Li, S., Tao, M., Yue, F., Hong, W., Feng, S., & Jing, N. (2025) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2025.02.007 · Cited by 9
Elia, A., Parodi‐Rullán, R. M., Vázquez‐Torres, R., Carey, A. M., Zhao, H., Javadov, S. A., & Fossati, S. (2026) · Advanced Science · doi:10.1002/advs.202511924 · Cited by 9
Nanomechanics of Amyloid Materials Studied by Atomic Force Microscopy
Zeng, G., Duan, Y., Besenbacher, F., & Dong, M. (2012) · InTech eBooks · doi:10.5772/36342 · Cited by 8
Effect of the Surface Chemistry of Insulin Fibrils on the Aggregation Rate
Hsieh, S., Hsieh, C., Chou, H., Chang, C., & Chu, L. (2013) · ChemPhysChem · doi:10.1002/cphc.201300838 · Cited by 8
Intracellular Cleavage of Amyloid β by a Viral Protease NIa Prevents Amyloid β-Mediated Cytotoxicity
Shin, B., Oh, H., Park, S. M., Han, H.-E., Ye, M., Song, W. K., & Park, W. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098650 · Cited by 8
Samy, A. S., & Igwe, O. J. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9670-8 · Cited by 8
Fontana, I. C., Ferreira, P. C. L., Miron, D., Santos, L. E., Ferreira, S. T., Souza, D. O., Gosmann, G., Zimmer, E. R., & Zimmer, A. R. (2021) · Journal of Chromatography A · doi:10.1016/j.chroma.2021.462024 · Cited by 8
Probing Amyloid Nanostructures Using Photoluminescent Metal Complexes
Jiang, B., & Martı́, A. A. (2021) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.202100422 · Cited by 8
Conti, E., ImmunAD-Brianza Network, Grana, D., Angiulli, F., Karantzoulis, A., Villa, C., Combi, R., Appollonio, I. M., Ferrarese, C., & Tremolizzo, L. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230239 · Cited by 8
Haynes, K. A., Smith, T. K., Preston, C. J., & Hegde, A. N. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00068 · Cited by 8
Assessing Aβ Aggregation State by Atomic Force Microscopy
Legleiter, J. A. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-744-0_5 · Cited by 8
Ng, J. T. Y., Kamm, R. D., Wohland, T., & Kraut, R. S. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.04.030 · Cited by 8
Frigori, R. B., da Silva, F. L. B., Carvalho, P. P. D., & Alves, N. A. (2020) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.0c01360 · Cited by 8
Vilardo, E., & Rossmanith, W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065609 · Cited by 8
Pino‐Cuevas, A., Raposinho, P., Fernandes, C., Paulo, A., Abram, U., Carballo, R., & Vázquez-López, E. M. (2019) · Future Medicinal Chemistry · doi:10.4155/fmc-2019-0013 · Cited by 8
Investigation of the self-assembly of hydrophobic self-complementary ionic tetrapeptides
Desii, A., Duce, C., Ghezzi, L., Monti, S., Solaro, R., & Tinè, M. R. (2009) · Journal of Thermal Analysis and Calorimetry · doi:10.1007/s10973-009-0277-z · Cited by 8
Soluble CSF1R promotes microglial activation and amyloid clearance in Alzheimer’s disease
Zhang, L., Chen, K., Zeng, R., Bu, G., & Chen, X.-F. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03558-5 · Cited by 7
Light on Alzheimer’s disease: from basic insights to preclinical studies
Mi, J., Liu, C., Chen, H., Qian, Y., Zhu, J., Zhang, Y., Liang, Y., Wang, L., & Ta, D. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1363458 · Cited by 8
He, C.-Y., Tian, D., Chen, S.-H., Jin, W., Cheng, Y., Xin, J., Li, W., Zeng, G., Tan, C., Jian, J.-M., et al. (2022) · Neuroscience Bulletin · doi:10.1007/s12264-022-00936-4 · Cited by 8
Bellingacci, L., Canonichesi, J., Sciaccaluga, M., Megaro, A., Mazzocchetti, P., Mauro, M. D., Costa, C., Filippo, M. D., Pettorossi, V. E., & Tozzi, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031377 · Cited by 7
Shang, N.-Y., Huang, L., Lan, J., Kang, Y.-Y., Tang, J., Wang, H., Li, X., Sun, Z., Chen, Q.-Y., Liu, M., et al. (2024) · Acta Pharmacologica Sinica · doi:10.1038/s41401-024-01240-9 · Cited by 7
Sanislav, O., Tetaj, R., Metali, Ratcliffe, J., Phillips, W., Klein, A. R., Sethi, A., Zhou, J., Mezzenga, R., Saxer, S., et al. (2024) · Nanoscale · doi:10.1039/d4nr03030c · Cited by 7
Amyloid capture and aggregation inhibition by human serum albumin
Cora, D., Al‐Soufi, W., & Novo, M. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.140367 · Cited by 7
Challenges in understanding the structure/activity relationship of Aβ oligomers
Pilkington, A. W., & Legleiter, J. A. (2019) · AIMS Biophysics · doi:10.3934/biophy.2019.1.1 · Cited by 7
Electrochemical assessment of dielectric damage to phospholipid bilayers by amyloid β-Oligomers
Budvytytė, R., Ambrulevičius, F., Jankaitytė, E., & Valinčius, G. (2022) · Bioelectrochemistry · doi:10.1016/j.bioelechem.2022.108091 · Cited by 7
Discovery of Y-Shaped Supramolecular Polymers in a Self-Assembling Peptide Amphiphile System
Wang, Y., Su, H., Wang, Y., & Cui, H. (2022) · ACS Macro Letters · doi:10.1021/acsmacrolett.2c00630 · Cited by 8
Curcumin tautomerization in the mechanism of pentameric amyloid- β42 oligomers disassembly
Matsui, A., Bellier, J., Hayashi, D., Ishibe, T., Nakamura, Y., Taguchi, H., Naruse, N., & Mera, Y. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.04.076 · Cited by 7
Bouvet, P., Gea, P. D., Aimard, M., Chounlamountri, N., Honnorat, J., Delcros, J., Salin, P. A., & Meissirel, C. (2023) · Aging Cell · doi:10.1111/acel.13907 · Cited by 9
Immunotherapy for Alzheimer‘s Disease
Steinitz, M. O. (2009) · Immunotherapy · doi:10.2217/imt.09.3 · Cited by 7
Chronochemistry in neurodegeneration
Pastore, A., & Adinolfi, S. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00020 · Cited by 7
Why Alzheimer’s is a Disease of Memory: Synaptic Targeting by Pathogenic Aβ Oligomers (ADDLs)
Klein, W. L., Felice, F. G. D., Lacor, P. N., Lambert, M. P., & Zhao, W.-Q. (2008) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-540-76330-7_9 · Cited by 7
Grasso, G., Komatsu, H., & Axelsen, P. H. (2017) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2017.06.007 · Cited by 8
Song, H., Ma, X., Xu, J., Song, Q., Meng, H., Gu, X. Q., Zhang, Q., Hou, L., Chen, L., Huang, Y., et al. (2018) · Nano Research · doi:10.1007/s12274-018-2107-8 · Cited by 7
Staniszewski, A., Zhang, H., Asam, K. R., Pitstick, R., Kavanaugh, M. P., Arancio, O., & Nicholls, R. E. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.2983-19.2020 · Cited by 7
Mulder, C. K., Dong, Y., Brugghe, H. F., Timmermans, H., Tilstra, W., Westdijk, J., van Riet, E., STEEG, H. V., Hoogerhout, P., & Eisel, U. L. M. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-151136 · Cited by 7
Metadata
- Authors
- Stine, W. B., Dahlgren, K. N., Krafft, G. A., & LaDu, M. J.
- Affiliations
- Northwestern University (US)
- Corresponding author
- LaDu, Mary Jo
- ORCID
- LaDu, Mary Jo
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-03
- Volume
- 278
- Issue
- 13
- Pages
- 11612-11622
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2133631618
- Cited by
- 1,015
- References
- 74
- Citations by year
- 2026: 40 · 2025: 39 · 2024: 37 · 2023: 39 · 2022: 34 · 2021: 49 · 2020: 37 · 2019: 40 · 2018: 33 · 2017: 46 · 2016: 49 · 2015: 42 · 2014: 60 · 2013: 52 · 2012: 69
- FWCI
- 19.08
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Alzheimer's Association
- Northwestern University
- National Institutes of Health (1p01ag015501-01, 5r01ag013496-05)
- National Institute on Aging (R01AG019121, AG-15501, AG 19121, AG13496)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- amyloid-beta, amyloid-beta 42, oligomerization, fibril formation, Alzheimer's disease, neurotoxicity, peptide aggregation, solution conditions, familial Alzheimer's disease mutations, amyloid plaques, peptide conformation
- MeSH terms
- Biopolymers, Circular Dichroism, Electrophoresis, Polyacrylamide Gel, Peptide Fragments, Solubility, Blotting, Western, Amyloid beta-Peptides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review